At Jazz Pharmaceuticals, our purpose is to innovate to transform the lives of patients and their families.

We are dedicated to developing life-changing medicines for people with rare diseases — often with limited or no therapeutic options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again.

We have a diverse portfolio of marketed medicines, including leading therapies addressing rare epilepsies, cancers, and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics. 

MODEYSO is a prescription medicine used to treat adults and children 1 year of age and older with a certain type of brain tumor called diffuse midline glioma that has a specific “H3 K27M” gene mutation and has worsened after other treatments.

Learn more about MODEYSO here.